The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
Trifluoro-methanesulfonic acid 8-(3-nitro-phenyl)-[1,7]naphthyridin-6-yl ester ID: ALA351900
PubChem CID: 10810934
Max Phase: Preclinical
Molecular Formula: C15H8F3N3O5S
Molecular Weight: 399.31
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: O=[N+]([O-])c1cccc(-c2nc(OS(=O)(=O)C(F)(F)F)cc3cccnc23)c1
Standard InChI: InChI=1S/C15H8F3N3O5S/c16-15(17,18)27(24,25)26-12-8-10-4-2-6-19-13(10)14(20-12)9-3-1-5-11(7-9)21(22)23/h1-8H
Standard InChI Key: ZHSRABCDAAITJX-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 29 0 0 0 0 0 0 0 0999 V2000
0.2167 -0.4875 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
0.7292 -0.1792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2833 -3.7875 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.3083 -0.7875 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.3333 -2.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.8208 -1.0917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.8208 -1.7000 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.8583 -1.7042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3333 -2.6000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.8083 -3.4917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8583 -1.1042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.8083 -2.9000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.1958 0.2208 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.7167 -1.2500 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.2708 -4.3792 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.3458 -0.8000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3708 -2.0042 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.3042 -3.7000 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.1917 0.1000 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1.3167 -0.3917 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
0.8167 0.4375 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
-1.8458 -2.9042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3208 -3.8000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8458 -3.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3708 -0.8000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8958 -1.7042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8958 -1.1000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 10 1 0
4 1 1 0
5 7 1 0
6 4 1 0
7 6 2 0
8 11 1 0
9 5 1 0
10 12 2 0
11 16 2 0
12 9 1 0
13 1 2 0
14 1 2 0
15 3 1 0
16 6 1 0
17 8 1 0
18 3 2 0
19 2 1 0
20 2 1 0
21 2 1 0
22 9 2 0
23 24 2 0
24 22 1 0
25 11 1 0
26 27 1 0
27 25 2 0
8 5 2 0
17 26 2 0
23 10 1 0
M CHG 2 3 1 15 -1
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 399.31Molecular Weight (Monoisotopic): 399.0137AlogP: 3.43#Rotatable Bonds: 4Polar Surface Area: 112.29Molecular Species: NEUTRALHBA: 7HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 2.83CX LogP: 4.69CX LogD: 4.69Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.29Np Likeness Score: -1.22
References 1. Hersperger R, Bray-French K, Mazzoni L, Müller T.. (2000) Palladium-catalyzed cross-coupling reactions for the synthesis of 6, 8-disubstituted 1,7-naphthyridines: a novel class of potent and selective phosphodiesterase type 4D inhibitors., 43 (4): [PMID:10691693 ] [10.1021/jm991094u ]